Skip to content
The Policy VaultThe Policy Vault

Gimoti (metoclopramide nasal spray − Evoke) — Cigna

Diabetic gastroparesis

Initial criteria

  • Approval is not recommended for Gimoti for any indication due to insufficient clinical efficacy data.